Novavax makes appointment
This article was originally published in Scrip
Executive Summary
The US biopharmaceutical company Novavax has named Dr Gregory Glenn chief scientific officer. Dr Glenn was previously chief scientific officer and founder of IOMAI (now Intercell), an associate in international health at Johns Hopkins University's School of Public Health and a clinical and basic research scientist at Walter Reed Army Institute of Research.